Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: +86-173-20513646
Mobile: 17320513646
Tel: +86-173-20513646
Fax:
Province/state: Hu Bei
City: Wuhan
Street: Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
MaxCard:
CAS NO.2875067-17-5
1(10.0-10000)Milligram
We supply over 20000 types of spot impurity reference materials, with sufficient supply and same day delivery to meet customers' urgent needs for replenishment at any time. The company has its own research and development center and laboratory, and the team members have over ten years of experience in developing drug impurity reference standards. Our website www.molcoo.com covers over 98% of cutting-edge generic drug projects, with complete structural formulas that greatly save customers time in impurity structure analysis and inference. All products undergo strict quality control testing and provide relevant information such as COA, H-NMR, C-NMR, MS/GC-MS, HPLC/GC purity, QNMR quantification, TGA thermogravimetric analysis, IR infrared, UV ultraviolet, two-dimensional (COSY, NOESY, HMBC, HMQC), etc. These structural confirmation spectra ensure quality and reliability. Our products have a wide range of categories, fast delivery time, good quality, and low prices, which can quickly solve various customer needs such as replenishment and consistency evaluation.
Suzetrigine Impurity 6
Product Information
Product Code: S054006
English Name: Suzetrigine Impurity 6
English Alias: (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonitrile
CAS No.:2875067-17-5
Molecular Formula: C??H??F?NO?
Molecular Weight: 335.27
Advantages
High Purity and Precise Structure: Structure confirmed by NMR and HRMS, with ≥99.0% purity (HPLC), providing a reliable standard for Suzetrigine impurity analysis.
Excellent Stability: Stored at 2-8℃ in a sealed, light-protected environment, it has a shelf life of 24 months, with <0.5% degradation in solution (e.g., acetonitrile) within 1 month, ensuring stable detection data.
Strong Regulatory Compliance: Meets international pharmaceutical regulatory standards of ICH, FDA, etc., helping pharmaceutical companies meet impurity control requirements and ensure drug quality.
Applications
Quality Control Testing: Used for HPLC and LC-MS detection of Impurity 6 in Suzetrigine API and formulations, strictly controlling impurity content to meet pharmacopoeia and regulatory standards.
Process Optimization Research: Monitor the generation of Impurity 6 during Suzetrigine synthesis. Optimize the process by adjusting parameters such as reaction temperature, raw material ratio, and reaction time to reduce impurity generation.
Analytical Method Validation: Serves as a reference standard for developing and validating Suzetrigine impurity detection methods, evaluating method specificity, sensitivity, and repeatability to ensure reliable analytical results.
Stability Studies: Track changes in Impurity 6 content during accelerated stability tests (e.g., 60℃/RH75%) and long-term stability tests, evaluate its impact on drug stability, and provide data support for determining drug shelf life and storage conditions.
Background Description
As a novel drug, Suzetrigine requires strict impurity control during R&D and production to ensure safety and efficacy. Impurity 6, a potential by-product or residual raw material impurity in Suzetrigine synthesis, contains a nitrile group that may affect the drug's physicochemical properties and pharmacological activity. With the increasingly strict global pharmaceutical regulatory requirements, research and control of Suzetrigine impurities have become crucial for building a drug quality system. Studying Impurity 6 helps improve drug quality standards and ensure patient safety.
Research Status
Detection Technology: UPLC-MS/MS is used with a C18 column (1.7μm, 2.1×100mm) and 0.1% formic acid water-acetonitrile gradient elution, completing separation within 1.8 minutes with a detection limit of 0.003 ng/mL, significantly enhancing impurity detection sensitivity and efficiency.
Formation Mechanism: Research shows that Impurity 6 may originate from the cyanidation step in Suzetrigine synthesis, resulting from side reactions between unreacted halogenated substances and cyanide in raw materials. Optimizing the dosage of cyanidation reagents and controlling the reaction pH at weakly alkaline levels (pH 8-9) can reduce impurity content by over 70%.
Safety Evaluation: Preliminary toxicological experiments indicate that Impurity 6 has certain toxicity to in vitro cells (e.g., HEK293) at high concentrations, but the specific mechanism remains unclear. Current drug quality standards set its limit at ≤0.1%, and further animal experiments are needed to evaluate its long-term toxicity and potential risks.
WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com
NOTE!
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com
NEW IN STOCK!
The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!